Abnormal Vaginal Microbiota Associated with miRNA Targeting the HIV-Host Interactome
Authors:
- Raina N. FichorovaRFRaina N. Fichorova
- Paula F. T. Cezar-De-MelloPCPaula F. T. Cezar-De-Mello
- Jonathan M. DreyfussJDJonathan M. Dreyfuss
- Hidemi YamamotoHYHidemi Yamamoto
- Pai-Lien ChenPCPai-Lien Chen
- Pan HuiPHPan Hui
- Xiaoming GaoXGXiaoming Gao
- Charles MorrisonCMCharles Morrison
- Robert BarbieriRBRobert Barbieri
- Gustavo F. DoncelGDGustavo F. Doncel
Preprint
Abstract
Understanding the molecular mechanisms underlying the ability of vaginal dysbiosis to alter the mucosal barrier to HIV acquisition is an essential step toward prevention. We hypothesized that micro(mi)-RNAs dysregulated by vaginal pathobiont bacteria epigenetically control host pathways exploited by the virus. The impact of these endogenous non-coding short RNAs on the anti-viral mucosal barrier function in the female reproductive tract is largely unknown. This study utilized cervicovaginal specimens collected during the luteal and follicular phase of the menstrual cycle along with data on age, race, ethnicity, education, and body mass index from 141 healthy reproductive-age women confirmed negative for sexually transmitted infections. Vaginal microbiota was classified by Nugent scoring. Shot-gun vaginal microbiome sequencing and metagenome taxonomic classification was performed on a subset of 21 women. Levels of miRNAs in exosomes isolated from cervicovaginal secretions were quantified using the EdgeSeq-NextGen global transcriptome platform. Differential expression (DE) was determined using R. Epigenetic target prediction was performed using MirTarBase. MiRNA profiles varied by both Nugent score categories (0-3 scores = normal, 4-6 = intermediate, and 7-10 = bacterial vaginosis, BV) and by metagenome classification. Higher microbiome diversity was associated with higher number of significantly dysregulated miRNAs (588 in BV compared to Nugent 0-3 versus 42 in Nugent 4-6 compared to Nugent 0-3, false discovery rate FDRG. vaginalis -dominated compared to L. crispatus -dominated metagenomes included 24 DE miRNAs (92% overlap with BV by Nugent score) and 112 validated target genes. BV-dysregulated miRNA mediated the immunosuppressive effects of BV on cytokine levels previously associated with HIV acquisition risk. The gene ontology predictions based on BV-dysregulated miRNAs identified enrichment for 445 downregulated and 50 upregulated genes previously validated as part of the HIV-host interactome. miRNAs mediation revealed a mechanism of suppressed immunity by BV predictive of HIV risk. In conclusion, miRNAs dysregulated by vaginal dysbiosis may facilitate immune imbalance and cellular pathways associated with HIV risk.Keywords
Funding Information
- the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (R01HD099091)
This publication has 43 references indexed in Scilit:
- Interleukin-8: An evolving chemokineCytokine, 2022
- High-throughput mediation analysis of human proteome and metabolome identifies mediators of post-bariatric surgical diabetes controlNature Communications, 2021
- A phase I randomized safety study of a single-size silicone rubber diaphragm used with or without a lactic-acid-containing diaphragm gelContraception, 2019
- MicroRNAs at the Host–Bacteria Interface: Host Defense or Bacterial OffenseTrends in Microbiology, 2019
- A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and PregnancyAIDS Research and Human Retroviruses, 2018
- HIV–host interactome revealed directly from infected cellsNature Microbiology, 2016
- Cross-talk among flesh-eatingAeromonas hydrophilastrains in mixed infection leading to necrotizing fasciitisProceedings of the National Academy of Sciences, 2016
- Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal ImmunityAIDS Research and Human Retroviruses, 2015
- Many roads to maturity: microRNA biogenesis pathways and their regulationNature Cell Biology, 2009
- Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infectionsAmerican Journal of Obstetrics and Gynecology, 2000